Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)

NCT04776239 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Ischemic Heart Disease

Interventions

DRUG: 100 million Allogeneic Mesenchymal Human Stem Cells
OTHER: Placebo

Sponsor

Joshua M Hare

Collaborators

[object Object]